Article Versions Notes

Sever B, Altıntop MD, Özdemir A, Akalın Çiftçi G, Ellakwa DE, Tateishi H, Radwan MO, Ibrahim MAA, Otsuka M, Fujita M, et al. In Vitro and In Silico Evaluation of Anticancer Activity of New Indole-Based 1,3,4-Oxadiazoles as EGFR and COX-2 Inhibitors. Molecules. 2020; 25(21):5190. https://doi.org/10.3390/molecules25215190

Sever, Belgin, Mehlika Dilek Altıntop, Ahmet Özdemir, Gülşen Akalın Çiftçi, Doha E. Ellakwa, Hiroshi Tateishi, Mohamed O. Radwan, Mahmoud A. A. Ibrahim, Masami Otsuka, Mikako Fujita, and et al. 2020. "In Vitro and In Silico Evaluation of Anticancer Activity of New Indole-Based 1,3,4-Oxadiazoles as EGFR and COX-2 Inhibitors" Molecules 25, no. 21: 5190. https://doi.org/10.3390/molecules25215190

Sever, B., Altıntop, M. D., Özdemir, A., Akalın Çiftçi, G., Ellakwa, D. E., Tateishi, H., Radwan, M. O., Ibrahim, M. A. A., Otsuka, M., Fujita, M., Ciftci, H. I., & Ali, T. F. S. (2020). In Vitro and In Silico Evaluation of Anticancer Activity of New Indole-Based 1,3,4-Oxadiazoles as EGFR and COX-2 Inhibitors. Molecules, 25(21), 5190. https://doi.org/10.3390/molecules25215190